Ionis Pharmaceuticals (IONS) Assets Average (2010 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Assets Average of $3.2 billion for Q2 2026, up 11.15% year-over-year from $2.9 billion in Q2 2025, and down 7.59% quarter-over-quarter from $3.5 billion in Q1 2026.
Ionis Pharmaceuticals (IONS) Assets Average (2010 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Assets Average history runs 17 years deep, the most recent figure standing at $3.2 billion for Q2 2026.
- In Q2 2026, Assets Average rose 11.15% year-over-year to $3.2 billion; the TTM figure through Jun 2026 stood at $3.2 billion (up 11.15% YoY), while the FY2025 annual figure was $3.3 billion, up 8.91% from the prior year.
- Assets Average for Q2 2026 stood at $3.2 billion, down from $3.5 billion in the prior quarter.
- The five-year high for Assets Average was $3.5 billion in Q1 2026, with the low at $2.4 billion in Q3 2022.
- The 5-year median for Assets Average is $2.9 billion (2025), against an average of $2.9 billion.
- The sharpest annual moves came in 2023 and 2024: Assets Average gained 21.05% in 2023, then retreated 6.85% in 2024.
- Ionis Pharmaceuticals' Assets Average stood at $2.5 billion in 2022, then rose by 19.54% to $3.0 billion in 2023, then rose by 2.71% to $3.0 billion in 2024, then gained by 7.76% to $3.3 billion in 2025, then declined by 1.72% to $3.2 billion in 2026.
- Business Quant data shows IONS's Assets Average at $3.2 billion in Q2 2026, $3.5 billion in Q1 2026, and $3.3 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn | 3.22 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.22 Bn |
| Mar 31, 2026 | 3.49 Bn |
| Dec 31, 2025 | 3.28 Bn |
| Sep 30, 2025 | 3.01 Bn |
| Jun 30, 2025 | 2.90 Bn |
| Mar 31, 2025 | 2.91 Bn |
| Dec 31, 2024 | 3.04 Bn |
| Sep 30, 2024 | 2.89 Bn |
| Jun 30, 2024 | 2.73 Bn |
| Mar 31, 2024 | 2.88 Bn |
| Dec 31, 2023 | 2.96 Bn |
| Sep 30, 2023 | 2.95 Bn |
| Jun 30, 2023 | 2.93 Bn |
| Mar 31, 2023 | 2.71 Bn |
| Dec 31, 2022 | 2.48 Bn |
| Sep 30, 2022 | 2.44 Bn |
| Jun 30, 2022 | 2.49 Bn |
| Mar 31, 2022 | 2.57 Bn |
| Dec 31, 2021 | 2.51 Bn |
| Sep 30, 2021 | 2.46 Bn |